Targeting heparan sulfate proteoglycan-assisted endocytosis as a COVID-19 therapeutic option
A drug repurpose screen targeting HSPG-dependent endocytosis identifies pharmacologically active endocytosis inhibitors that also abrogate the entry of SARS-CoV and SARS-CoV-2. l